HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Hirata Selected Research

Ophthalmoplegia (External Ophthalmoplegia)

8/2006Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
11/2005Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome.
5/2001Antecedent symptoms in Guillain-Barré syndrome: an important indicator for clinical and serological subgroups.
3/2001Fine specificity of anti-GQ1b IgG and clinical features.
1/2001Acute ophthalmoparesis (without ataxia) associated with anti-GQ1b IgG antibody: clinical features.
8/2000Unilateral ophthalmoparesis and limb ataxia associated with anti-GQ1b IgG antibody.
5/2000Ataxic Guillain-Barré syndrome with anti-GQ1b antibody: relation to Miller Fisher syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


K Hirata Research Topics

Disease

30Neoplasms (Cancer)
04/2010 - 01/2000
18Guillain-Barre Syndrome
10/2011 - 03/2000
14Stomach Neoplasms (Stomach Cancer)
07/2013 - 01/2000
9Pancreatic Neoplasms (Pancreatic Cancer)
07/2018 - 01/2000
9Neoplasm Metastasis (Metastasis)
11/2015 - 02/2000
9Miller Fisher Syndrome (Fisher Syndrome)
05/2008 - 05/2000
9Infections
05/2008 - 03/2000
8Carcinoma (Carcinomatosis)
09/2005 - 02/2000
7Colorectal Neoplasms (Colorectal Cancer)
07/2007 - 01/2000
7Ophthalmoplegia (External Ophthalmoplegia)
08/2006 - 05/2000
6Breast Neoplasms (Breast Cancer)
09/2008 - 01/2000
6Reperfusion Injury
01/2005 - 01/2000
5Asthma (Bronchial Asthma)
09/2009 - 12/2000
4Chronic Obstructive Pulmonary Disease (COPD)
10/2019 - 10/2000
4Inflammation (Inflammations)
11/2012 - 06/2002
4Encephalitis (Encephalitis, Rasmussen)
05/2008 - 03/2001
4Ataxia (Dyssynergia)
11/2005 - 05/2000
4Ischemia
01/2005 - 11/2000
4Lymphatic Metastasis
06/2003 - 03/2000
4Colonic Neoplasms (Colon Cancer)
02/2001 - 01/2000
4Myocardial Infarction
08/2000 - 05/2000
3Critical Illness (Critically Ill)
08/2016 - 06/2012
3Body Weight (Weight, Body)
06/2012 - 01/2006
3Carcinogenesis
09/2008 - 07/2007
3Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
08/2005 - 06/2000
3Polyneuropathies (Polyneuropathy)
08/2005 - 06/2000
3Pain (Aches)
04/2000 - 02/2000
2Squamous Cell Carcinoma of Head and Neck
01/2020 - 05/2018
2Emphysema
10/2019 - 10/2003
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
10/2018 - 04/2000
2Hypoxia (Hypoxemia)
05/2018 - 06/2001
2REM Sleep Behavior Disorder
10/2011 - 06/2000
2Psoriasis (Pustulosis Palmaris et Plantaris)
06/2008 - 06/2005
2Wounds and Injuries (Trauma)
02/2006 - 01/2005
2Pulmonary Hypertension
07/2003 - 10/2000
2Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy)
01/2003 - 01/2001
2Lung Diseases (Lung Disease)
06/2002 - 05/2001
2Esophageal Neoplasms (Esophageal Cancer)
09/2001 - 02/2000
2Myocardial Ischemia (Ischemic Heart Diseases)
09/2001 - 07/2001
2Vascular Diseases (Vascular Disease)
08/2001 - 05/2000
2Diarrhea
05/2001 - 08/2000
2Vascular Remodeling
03/2001 - 02/2001

Drug/Important Bio-Agent (IBA)

13Immunoglobulin G (IgG)IBA
07/2018 - 05/2000
10AntibodiesIBA
10/2011 - 03/2000
10Proteins (Proteins, Gene)FDA Link
04/2010 - 06/2000
8GangliosidesIBA
11/2005 - 03/2000
5Fluorouracil (Carac)FDA LinkGeneric
11/2006 - 02/2000
5Messenger RNA (mRNA)IBA
12/2003 - 01/2000
5Immunoglobulin M (IgM)IBA
07/2001 - 06/2000
5CytokinesIBA
06/2001 - 01/2000
4Indicators and Reagents (Reagents)IBA
07/2013 - 11/2000
4AutoantibodiesIBA
05/2008 - 05/2005
4beta CateninIBA
03/2008 - 03/2002
4Cisplatin (Platino)FDA LinkGeneric
10/2007 - 02/2000
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2003 - 11/2000
4Telomerase (Telomerase Reverse Transcriptase)IBA
09/2001 - 10/2000
3Biomarkers (Surrogate Marker)IBA
01/2021 - 07/2013
3Glucose (Dextrose)FDA LinkGeneric
11/2015 - 03/2014
3LigandsIBA
11/2012 - 03/2005
3EpitopesIBA
11/2006 - 08/2000
3ganglioside M1b (GM1b)IBA
08/2006 - 03/2000
3A-Form DNA (A-DNA)IBA
11/2005 - 06/2003
3Intravenous Immunoglobulins (IVIG)FDA Link
08/2005 - 06/2004
3Complementary DNA (cDNA)IBA
12/2003 - 07/2001
3Biological ProductsIBA
12/2003 - 07/2000
3AntigensIBA
07/2001 - 04/2000
3Nitric Oxide (Nitrogen Monoxide)FDA Link
06/2001 - 02/2000
3Nitric Oxide Synthase (NO Synthase)IBA
06/2001 - 02/2000
2fluoromisonidazoleIBA
01/2020 - 05/2018
2Heat-Shock Proteins (Heat-Shock Protein)IBA
11/2012 - 11/2000
2Fluconazole (Zonal)FDA LinkGeneric
09/2012 - 06/2012
2maxacalcitolIBA
06/2008 - 06/2005
2Cholecalciferol (Vitamin D3)FDA Link
06/2008 - 06/2005
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
08/2005 - 05/2001
2sulfoquinovosylacylglycerolIBA
01/2005 - 09/2004
2Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
07/2003 - 10/2000
2RNA (Ribonucleic Acid)IBA
06/2003 - 03/2001
2Glycogen Synthase Kinase 3 betaIBA
06/2003 - 03/2002
2Vascular Endothelial Growth Factor CIBA
06/2003 - 09/2001
2Threonine (L-Threonine)FDA Link
06/2003 - 03/2002
2Serine (L-Serine)FDA Link
06/2003 - 03/2002
2Peroxynitrous Acid (Peroxynitrite)IBA
02/2003 - 06/2002
2Oxidants (Oxidizing Agents)IBA
02/2003 - 06/2002
2AntioxidantsIBA
02/2003 - 06/2002
2ConnexinsIBA
01/2003 - 01/2001
2Codon (Codons)IBA
03/2002 - 07/2000
2Anti-Infective Agents (Microbicides)IBA
10/2001 - 08/2000
2EnzymesIBA
07/2001 - 06/2000
2sulfate-3-glucuronyl paraglobosideIBA
05/2001 - 06/2000
2Myelin-Associated GlycoproteinIBA
05/2001 - 06/2000
2Thallium-201IBA
04/2001 - 05/2000
2Irinotecan (Camptosar)FDA LinkGeneric
02/2001 - 06/2000
2Interleukin-12 (IL 12)IBA
11/2000 - 01/2000
2iodofiltic acidIBA
08/2000 - 05/2000

Therapy/Procedure

18Therapeutics
05/2008 - 02/2000
4Drug Therapy (Chemotherapy)
07/2000 - 02/2000
3Plasma Exchange
08/2005 - 10/2000
2Combination Drug Therapy (Combination Chemotherapy)
10/2007 - 02/2000
2Aftercare (After-Treatment)
06/2001 - 02/2000
2Ligation
03/2001 - 02/2001